Skip to content

Endoscopic Ultrasound (EUS) Guided Fine Needle Aspiration (FNA) EUS-FNA of Solid Pancreatic Mass Lesions Using a Novel Corkscrew Technique: a Pilot Study

EUS-guided Fine Needle Tissue Acquisition of Solid Pancreatic Mass Lesions Using a Novel Corkscrew Technique: a Pilot Study

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02116322
Enrollment
4
Registered
2014-04-16
Start date
2014-04-30
Completion date
2016-05-31
Last updated
2017-07-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic Cancer

Brief summary

This research is being done to investigate if a new technique to biopsy the pancreas will lead to a larger amount tissue material that can be analyzed. Investigators have called the technique the corkscrew technique and believe it will allow obtaining a larger biopsy sample during the endoscopic ultrasound examination. The corkscrew technique uses a clockwise rotational movement to drive the needle into the pancreatic mass (like a wine bottle opener twists and buries itself into a cork). It is believed that this will lead to a better biopsy sample than the usual way and therefore result in a higher chance of a diagnosis.

Interventions

PROCEDUREEUS-FNA with Corkscrew technique
DEVICEExpect 19 G Flex needle

Sponsors

Johns Hopkins University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* In-patients and out-patients between the age of 18 and 90 years with solid pancreatic masses presenting for EUS-Fine Needle Aspiration (FNTA)

Exclusion criteria

* Uncorrectable coagulopathy (INR \> 1.5) * Uncorrectable thrombocytopenia (platelet \< 50,000) * Uncooperative patients * Pregnant women (women of childbearing age will undergo urine pregnancy testing, which is routine for all endoscopic procedures) * Refusal to consent form * Prior negative FNTA * In situ metallic biliary stents * Predominantly cystic lesions * Inaccessible lesions to EUS

Design outcomes

Primary

MeasureTime frame
Number of Participants With Adverse Events as a Measure of Safety30 days

Secondary

MeasureTime frameDescription
Diagnostic Yield of the FNA Using Corkscrew Technique30 daysDiagnostic yield was defined as the proportion of masses in which the amount of FNA-obtained cellular material was enough for the histopathologist to make the pathological diagnosis.

Countries

United States

Participant flow

Recruitment details

Patients were enrolled between 7/18/14 and 2/18/15 in an academic tertiary center

Pre-assignment details

A total of 4 participants were enrolled. However, 3 participants were excluded before being assigned to the study arm because the performing endoscopist didn't find it possible to do the procedure due to the unfavorable size of the mass or technical difficulty.

Participants by arm

ArmCount
Pancreatic Mass
Patients with pancreatic mass presenting for EUS-FNA EUS-FNA with Corkscrew technique Expect 19 G Flex needle
1
Total1

Baseline characteristics

CharacteristicPancreatic Mass
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
1 Participants
Age, Categorical
Between 18 and 65 years
0 Participants
Age, Continuous80 years
Sex: Female, Male
Female
0 Participants
Sex: Female, Male
Male
1 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
0 / 1
serious
Total, serious adverse events
0 / 1

Outcome results

Primary

Number of Participants With Adverse Events as a Measure of Safety

Time frame: 30 days

ArmMeasureValue (NUMBER)
Pancreatic MassNumber of Participants With Adverse Events as a Measure of Safety0 participants
Secondary

Diagnostic Yield of the FNA Using Corkscrew Technique

Diagnostic yield was defined as the proportion of masses in which the amount of FNA-obtained cellular material was enough for the histopathologist to make the pathological diagnosis.

Time frame: 30 days

ArmMeasureValue (NUMBER)
Pancreatic MassDiagnostic Yield of the FNA Using Corkscrew Technique0 percentage of masses

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026